COVID-19 and Antibiotic Resistance

The coronavirus COVID-19 pandemic is the defining global health crisis of our time and the greatest challenge we have faced since World War Two. During the current COVID-19 pandemic there are potential threats that could affect antimicrobial stewardship activities and drive antimicrobial resistance. The use of antibiotics in people with COVID-19 could result in increased resistance to the drugs' benefits among the wider population. Patients hospitalized as a result of the virus are being given a combination of medications to prevent possible secondary bacterial infections.

Antibiotics underpin all of modern medicine, but AMR is an issue that could impact millions of lives in the decades to come. Currently, the COVID-19 pandemic is causing immense suffering and loss of life across the globe, but AMR has been and will remain one of the most significant threats to global human health.

  • COVID-19
  • AMR
  • Antibiotics
  • Antimicrobial stewardship

Related Conference of COVID-19 and Antibiotic Resistance

April 28-29, 2021

31st Annual European Pharma Congress

London, UK
April 28-29, 2021

14th European Biosimilars Congress

London, UK
May 10-11, 2021

20th Annual Meet on Pharmaceutical Sciences

Yokohama, Japan
May 12-12, 2021

27th Cognitive Neuroscience Congress

London, UK
May 17-17, 2021

Annual Meet on Pharmacovigilance & Drug Safety

Tokyo, Japan
May 17-18, 2021

8th European Biopharma Congress

Prague, Czech Republic
May 17-18, 2021

24th Asia Pacific Pharma Congress

Melbourne, Australia
June 07-08, 2021

2nd European Conference on Pharmacovigilance and Drug Safety

Prague, Czech Republic
June 21-22, 2021

1 st Global Summit on Generic Drugs and Quality Control

Prague, Czech Republic
July 06-07, 2021

14th Global Pharmacovigilance And Clinical Trials Summit

Albufeira, Portugal
July 10-11, 2021

2 nd Pharma Expo China

Tokyo, Japan
July 26-27, 2021

36th World Pharmacology and Therapeutics Forum

Paris, France
July 30-30, 2021

12th World Congress on Bioavailability and Bioequivalence

Prague, Czech Republic
August 16-17, 2021

Global summit on Cosmetic & Reconstructive Surgery

Tokyo, Japan
August 16-17, 2021

34rd World Congress on Pharmacology

London, UK
August 23-24, 2021

7th World Congress on Medicinal Plants and Marine Drugs

Prague, Czech Republic
August 30-31, 2021

20th Medicinal & PharmaceuticalSciences Congress

London, UK
September 13-14, 2021

3rd World Congress on Drug Discovery and Drug Design

Tokyo, Japan
September 17-18, 2021

9th International Conference on Clinical Trials

Montreal, Canada
September 20-21, 2021

Asia Pacific Pharmaceutics & Drug Delivery Congress

Tokyo, Japan
September 27-28, 2021

2 nd World Pharma Expo

Tokyo, Japan
October 05-06, 2021

International Congress on Drug Delivery

Auckland, Newzealand
October 21-22, 2021

2nd Annual Congress on Antibiotics and Bacterial Infections

Geneva, Switzerland
October 29-30, 2021

14th World Drug Delivery Summit

Vancouver, Canada
October 29-30, 2021

12th Annual Biomarkers and Clinical Research Congress

Vancouver, Canada
November 16-17, 2021

World Congress on Biologics and Biosimilars

Osaka, Japan
November 26-27, 2021

World Biosimilars & Biologics Congress

Vancouver, Canada
December 02-03, 2021

17th Annual Congress on Pharmacology and Toxicology

Tokyo, Japan
December 02-03, 2021

International Conference on Bio Pharmaceutics

Auckland, Newzealand
December 07-08, 2021

2nd International Conference on Biotechnology and Healthcare

Auckland, Newzealand
December 15-16, 2021

12th World Congress on Bioavailability and Bioequivalence

Bali, Indonesia

COVID-19 and Antibiotic Resistance Conference Speakers

Recommended Sessions

Related Journals

Are you interested in